Loading...
Loading...
By MBN Staff - Mon, 11/24/2025 - 12:20
WHO’s GAP-f outlines new steps to expand access to age-appropriate medicines as global demand for pediatric treatments grows.
https://mexicobusiness.news/tag/type-2-diabetes
More Health
By MBN Staff - Mon, 09/22/2025 - 17:11
Lilly reports that Mounjaro cut blood sugar and BMI in children with type 2 diabetes, marking a milestone in pediatric diabetes care.
By MBN Staff - Mon, 08/18/2025 - 09:53
Eli Lilly reports that tirzepatide protects against adverse cardiovascular events, including cardiovascular death, myocardial infarction, or stroke.
By MBN Staff - Tue, 07/22/2025 - 08:01
Medtronic expands MiniMed 780G use in the European Union to children, pregnant women, and people with type 2 diabetes, following CE Mark approval.
By MBN Staff - Sat, 06/28/2025 - 09:32
New trial data shows promising results for two GLP-1 treatments for obesity and type 2 diabetes, with studies conducted in Mexico and other countries.
By Sofía Garduño - Thu, 06/26/2025 - 10:00
OpenAI examined the role of AI in biosciences, Pfizer advanced efforts to expand vaccine access, and WHO renewed its call for tobacco control.
By MBN Staff - Mon, 06/23/2025 - 12:23
Eli Lilly's once-weekly insulin showed similar glucose control to daily regimens across global Phase 3 trials, including participants in Mexico.
By María Jesús Salido Rojo - Wed, 05/07/2025 - 06:00
SmartDiabetes and TecDiabetes are pioneering value-based digital care to tackle chronic illness in Europe and in aging Mexico, writes María Salido.
By MBN Staff - Fri, 05/02/2025 - 08:22
Galmed signs a global deal to develop a sublingual Semaglutide formulation, targeting Mexico and international markets.
By MBN Staff - Fri, 04/25/2025 - 15:26
Lilly’s oral GLP-1 drug orforglipron met key goals in a Phase 3 trial, showing significant A1C and weight reductions in type 2 diabetes patients.
